成大生物
(688739)
| 流通市值：104.51亿 | | | 总市值：105.74亿 |
| 流通股本：4.12亿 | | | 总股本：4.16亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 358,395,731.16 | 1,676,241,143.62 | 1,302,689,599.82 | 880,692,770.15 |
| 营业收入 | 358,395,731.16 | 1,676,241,143.62 | 1,302,689,599.82 | 880,692,770.15 |
| 二、营业总成本 | 273,025,862.02 | 1,195,983,007.01 | 872,113,905.3 | 585,937,644.97 |
| 营业成本 | 86,447,677.95 | 286,002,805.26 | 222,550,389.8 | 151,290,019.1 |
| 税金及附加 | 5,030,834.78 | 22,627,720.02 | 16,947,394.51 | 11,349,759.91 |
| 销售费用 | 88,186,186.15 | 421,259,791.15 | 299,221,885.06 | 191,144,478.32 |
| 管理费用 | 52,503,772.74 | 236,765,506.25 | 166,310,583.93 | 109,948,872.63 |
| 研发费用 | 51,861,758.56 | 282,932,719.22 | 207,277,477.75 | 149,426,599.51 |
| 财务费用 | -11,004,368.16 | -53,605,534.89 | -40,193,825.75 | -27,222,084.5 |
| 其中:利息费用 | 168,872.28 | 1,578,015.37 | 643,979.17 | 442,940.01 |
| 其中:利息收入 | 10,955,568.33 | 54,945,255.59 | 41,015,216.17 | 27,281,549.39 |
| 加:公允价值变动收益 | 2,161,793.47 | -33,421,748.59 | -15,935,793.6 | -10,938,482.4 |
| 加:投资收益 | 4,408,104.7 | 15,549,868.15 | 14,609,762.67 | 8,228,475.14 |
| 资产处置收益 | - | 88,290.32 | 90,854.59 | 90,854.59 |
| 资产减值损失(新) | -8,142,887.42 | -75,387,882.53 | -26,455,350.8 | -20,060,706.72 |
| 信用减值损失(新) | -7,672,350.59 | -8,341,830 | -11,138,182.19 | -9,894,892.82 |
| 其他收益 | 4,315,669.53 | 26,903,599.28 | 15,240,836.32 | 11,541,396.88 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 80,440,198.83 | 405,648,433.24 | 406,987,821.51 | 273,721,769.85 |
| 加:营业外收入 | 39,931.87 | 115,860 | 111,700 | 109,700 |
| 减:营业外支出 | 327,884.65 | 2,739,355.12 | 1,937,324.57 | 1,676,764.6 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 80,152,246.05 | 403,024,938.12 | 405,162,196.94 | 272,154,705.25 |
| 减:所得税费用 | 7,934,240.8 | 60,203,383.85 | 75,464,068.9 | 51,941,395.28 |
| 六、净利润 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 | 220,213,309.97 |
| 持续经营净利润 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 | 220,213,309.97 |
| 归属于母公司股东的净利润 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 | 220,213,309.97 |
| (一)基本每股收益 | 0.18 | 0.83 | 0.8 | 0.53 |
| (二)稀释每股收益 | 0.18 | 0.83 | 0.8 | 0.53 |
| 九、综合收益总额 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 | 220,213,309.97 |
| 归属于母公司股东的综合收益总额 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 | 220,213,309.97 |
| 公告日期 | 2025-04-30 | 2025-04-24 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |